Continuous Levodopa Infusion Is Better-for Now

被引:1
作者
Nutt, John G. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Portland, OR 97239 USA
关键词
ADVANCED PARKINSONS-DISEASE; EXTRACELLULAR DOPAMINE; APOMORPHINE; CARBIDOPA; STRIATUM; THERAPY;
D O I
10.1002/mds.26169
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:443 / 445
页数:3
相关论文
共 21 条
[1]   The highs and lows of beta activity in cortico-basal ganglia loops [J].
Brittain, John-Stuart ;
Sharott, Andrew ;
Brown, Peter .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2014, 39 (11) :1951-1959
[2]   Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease [J].
Brod, Lissa S. ;
Aldred, Jason L. ;
Nutt, John G. .
MOVEMENT DISORDERS, 2012, 27 (06) :750-753
[3]   AROMATIC AMINO ACIDS AND MODIFICATION OF PARKINSONISM [J].
COTZIAS, GC ;
VANWOERT, MH ;
SCHIFFER, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (07) :374-&
[4]   MODIFICATION OF PARKINSONISM - CHRONIC TREATMENT WITH L-DOPA [J].
COTZIAS, GC ;
PAPAVASI.PS ;
GELLENE, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1969, 280 (07) :337-&
[5]   Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease:: implications for dyskinesias [J].
de la Fuente-Fernández, R ;
Sossi, V ;
Huang, ZG ;
Furtado, S ;
Lu, JQ ;
Calne, DB ;
Ruth, TJ ;
Stoessl, AJ .
BRAIN, 2004, 127 :2747-2754
[6]   TIME COURSE OF TOLERANCE TO APOMORPHINE IN PARKINSONISM [J].
GANCHER, ST ;
NUTT, JG ;
WOODWARD, WR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (05) :504-510
[7]   Dopamine release during sequential finger movements in health and Parkinson's disease: a PET study [J].
Goerendt, IK ;
Messa, C ;
Lawrence, AD ;
Grasby, PM ;
Piccini, P ;
Brooks, DJ .
BRAIN, 2003, 126 :312-325
[8]   A neurochennical closed-loop controller for deep brain stimulation: toward individualized smart neuromodulation therapies [J].
Grahn, Peter J. ;
Mallory, Grant W. ;
Khurram, Obaid U. ;
Berry, B. Michael ;
Hachmann, Jan T. ;
Bieber, Allan J. ;
Bennet, Kevin E. ;
Min, Hoon-Ki ;
Chang, Su-Youne ;
Lee, Kendall H. ;
Lujan, J. L. .
FRONTIERS IN NEUROSCIENCE, 2014, 8
[9]   Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat [J].
Jonkers, N ;
Sarre, S ;
Ebinger, G ;
Michotte, Y .
JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (05) :559-570
[10]  
LOTTI VJ, 1970, J PHARMACOL EXP THER, V172, P406